ImageneBio (IMA) Price to Sales (2021 - 2025)

ImageneBio has disclosed Price to Sales across 5 years of filings, most recently posting 77.21 for Q1 2025.

• In Q1 2025, Price to Sales changed N/A year-over-year to 77.21; the TTM figure through Sep 2025 stood at 16.16 (up 42.25% YoY), while the FY2023 annual figure was 10.38, up 68.07% from the prior year.
• Price to Sales came in at 77.21 for Q1 2025 at ImageneBio, up from 23.85 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 420.39 in Q2 2022 to a low of 17.36 in Q4 2021.
• Average Price to Sales over 5 years is 100.22, with a median of 71.15 recorded in 2022.
• Year-over-year, Price to Sales surged 715.21% in 2023 and sank 85.2% in 2024.
• Over 5 years, Price to Sales stood at 17.36 in 2021, then rose by 1.95% to 17.7 in 2022, then surged by 715.21% to 144.26 in 2023, then slumped by 83.47% to 23.85 in 2024, then soared by 223.7% to 77.21 in 2025.
• Per Business Quant data, the three most recent Price to Sales figures were 77.21 in Q1 2025, 23.85 in Q3 2024, and 144.26 in Q4 2023.